Associations between intravitreal anti-vascular endothelial growth factor therapy and adverse renal outcomes.

Chuang SH, Lin BH, Chen YP, Wu LC, Kuo YJ, Chang CH

Open source

DOI
10.1097/iae.0000000000005022
Published
2026 Sep 21
Container
Retina (Philadelphia, Pa.)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/iae.0000000000005022,
  title = {Associations between intravitreal anti-vascular endothelial growth factor therapy and adverse renal outcomes.},
  author = {Chuang SH and Lin BH and Chen YP and Wu LC and Kuo YJ and Chang CH},
  year = {2026},
  journal = {Retina (Philadelphia, Pa.)},
  doi = {10.1097/iae.0000000000005022},
  url = {https://doi.org/10.1097/iae.0000000000005022}
}

RIS

TY  - JOUR
TI  - Associations between intravitreal anti-vascular endothelial growth factor therapy and adverse renal outcomes.
AU  - Chuang SH
AU  - Lin BH
AU  - Chen YP
AU  - Wu LC
AU  - Kuo YJ
AU  - Chang CH
PY  - 2026
JO  - Retina (Philadelphia, Pa.)
DO  - 10.1097/iae.0000000000005022
UR  - https://doi.org/10.1097/iae.0000000000005022
ER  - 

APA

SH, C., BH, L., YP, C., LC, W., YJ, K., & CH, C. (2026). Associations between intravitreal anti-vascular endothelial growth factor therapy and adverse renal outcomes.. Retina (Philadelphia, Pa.). https://doi.org/10.1097/iae.0000000000005022

Source records